2HAFFNER SM, LEHTO S, RONNEMAA T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J]. N Engl J Med,1998,339(4) :229 -234.
3HOLMAN RR, PAUL SK, BETI-,IEL MA, et al. 10-year follow-upof intensive glucose control in type 2 diabetes [ J ]. N Engl J Med, 2008,359 ( 15 ) : 1577 - 1598.
4KAHN SE, HAFFNER SM, HEISE MA, et al. Glycemic durability of rosiglitazone, meffomin, or glyburide monotherapy [ J]. N Engl J Med ,2006,355 (23) :2427 - 2443.
5HANEFELD M, CAGATAY M, PETROWITSCH T, et al. Acarbose reduces the risk for myocardial infarction in type 2diabetic patients: meta-analysis of seven long-tern studies [ J ]. Eur Heart J,2004,25 (1) :10 -16.
6Yegnanarayan R,Suryavanshi M,Singh M. A comparative study of the glycemic control of various antidiabetic agents and the role of homocysteine in the therapy of type 2 diabetes mellitus[J].Journal of Diabetes and its Complications,2008,(02):104-111.doi:10.1016/j.jdiacomp.2006.09.001.
7Harris RA,Nishiyama SK,Wray DW. Ultrasound assessment of flow-mediated dilation[J].Hypertension,2010,(05):1075-1085.doi:10.1161/HYPERTENSIONAHA.110.150821.
8Gogg S,Smith U,Jansson PA. Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes:the role of endothelin-1[J].Diabetes,2009,(10):2238-2245.doi:10.2337/db08-0961.
9Loimaala A,Groundstroem K,Rinne M. Effect of long-term endurance and strength training on metabolic control and arterial elasticity in patients with type 2 diabetes mellitus[J].American Journal of Cardiology,2009,(07):972-977.doi:10.1016/j.amjcard.2008.12.026.
10Kasami R,Kaneto H,Katakami N. Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in type 2 diabetic patients with carotid atherosclerosis but without history of coronary artery disease[J].Diabetes Care,2011,(02):468-470.doi:10.2337/dc10-1222.
